Cynthia Blanco1, Lisa McGill-Vargas1, Cun Li2,3, Lauryn Winter1, Peter Nathanielsz2,3. 1. Department of Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. 2. Texas Pregnancy and Life-course Health Research Center, Department of Animal Science, University of Wyoming, Laramie, Wyoming, USA. 3. Texas Biomedical Research Institute, San Antonio, Texas, USA.
Abstract
BACKGROUND: Parenteral amino acid (AA) nutrition administration after premature birth is necessary to ensure adequate growth and neurodevelopment. However, optimizing safety and efficacy remains a major challenge. This study investigated the effects of intravenous AA administration on plasma AA profiles in premature baboons and infants. METHODS: Premature baboons were delivered by cesarean section at 125 days (67% gestation) and chronically ventilated. At 24 hours of life, a parenteral AA protocol comparable to the early and high AA regimens used in premature infants was initiated. Serial plasma AA concentrations were obtained on days of life (DOLs) 1, 3, and 7 and compared with concentrations at similar DOLs from preterm infants. Fetal baboon (165 ± 2 days; 89% gestation) and term baboon plasma AA concentrations were obtained for comparison. RESULTS: Premature baboons receiving early and high parenteral AA supplementation exhibited significant differences in plasma AA concentrations compared with fetuses. In particular, concentrations of leucine, isoleucine, valine, and ornithine were elevated (fold increase: 2.14, 2.03, 1.95, and 16.5, respectively; P < 0.001) on DOL 3 vs fetuses. These alterations mimicked those found in preterm infants. CONCLUSION: Early and high AA supplementation in extremely premature baboons significantly disrupted plasma AA concentrations. Elevated concentrations of branched-chain AAs and ornithine raise concerns for adverse neurodevelopmental outcomes. These results are consistent with those found in premature human infants and emphasize the need to optimize parenteral AA solutions for the unique metabolic requirements of premature infants. Improved technologies for rapid monitoring of AA concentrations during treatment are essential.
BACKGROUND: Parenteral amino acid (AA) nutrition administration after premature birth is necessary to ensure adequate growth and neurodevelopment. However, optimizing safety and efficacy remains a major challenge. This study investigated the effects of intravenous AA administration on plasma AA profiles in premature baboons and infants. METHODS: Premature baboons were delivered by cesarean section at 125 days (67% gestation) and chronically ventilated. At 24 hours of life, a parenteral AA protocol comparable to the early and high AA regimens used in premature infants was initiated. Serial plasma AA concentrations were obtained on days of life (DOLs) 1, 3, and 7 and compared with concentrations at similar DOLs from preterm infants. Fetal baboon (165 ± 2 days; 89% gestation) and term baboon plasma AA concentrations were obtained for comparison. RESULTS: Premature baboons receiving early and high parenteral AA supplementation exhibited significant differences in plasma AA concentrations compared with fetuses. In particular, concentrations of leucine, isoleucine, valine, and ornithine were elevated (fold increase: 2.14, 2.03, 1.95, and 16.5, respectively; P < 0.001) on DOL 3 vs fetuses. These alterations mimicked those found in preterm infants. CONCLUSION: Early and high AA supplementation in extremely premature baboons significantly disrupted plasma AA concentrations. Elevated concentrations of branched-chain AAs and ornithine raise concerns for adverse neurodevelopmental outcomes. These results are consistent with those found in premature humaninfants and emphasize the need to optimize parenteral AA solutions for the unique metabolic requirements of premature infants. Improved technologies for rapid monitoring of AA concentrations during treatment are essential.
Authors: Cynthia L Blanco; Alice K Gong; John Schoolfield; Belinda K Green; Wanda Daniels; Edward A Liechty; Rajam Ramamurthy Journal: J Pediatr Gastroenterol Nutr Date: 2012-05 Impact factor: 2.839
Authors: Cynthia Liudmilla Blanco; Alison Falck; Belinda Kay Green; John E Cornell; Alice Kim Gong Journal: J Pediatr Date: 2008-06-27 Impact factor: 4.406
Authors: Brenda B Poindexter; Richard A Ehrenkranz; Barbara J Stoll; Linda L Wright; W Kenneth Poole; William Oh; Charles R Bauer; Lu-Ann Papile; Jon E Tyson; Waldemar A Carlo; Abbot R Laptook; Vivek Narendran; David K Stevenson; Avroy A Fanaroff; Sheldon B Korones; Seetha Shankaran; Neil N Finer; James A Lemons Journal: Pediatrics Date: 2004-05 Impact factor: 7.124
Authors: Hester Vlaardingerbroek; Marijn J Vermeulen; Denise Rook; Chris H P van den Akker; Kristien Dorst; Josias L Wattimena; Andras Vermes; Henk Schierbeek; Johannes B van Goudoever Journal: J Pediatr Date: 2013-05-06 Impact factor: 4.406
Authors: Hassan M Ibrahim; Majied A Jeroudi; R J Baier; Ramasubbareddy Dhanireddy; Richard W Krouskop Journal: J Perinatol Date: 2004-08 Impact factor: 2.521